Biogen plans late-stage trial for Alzheimer’s treatment

(Reuters) – Biogen Idec Inc’s research chief on Tuesday said the company was planning a late-stage trial of its experimental treatment for Alzheimer’s disease after the drug cut brain plaque levels and improved cognition in a small early-stage study.

—> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *